Objective Medication-related osteonecrosis of the jaws (MRONJ) is a potentially severe
complication associated with antiresorptive or antiangiogenic therapies. Prior studies …

Medication‐related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse effect of
antiresorptive medications administered for control of osseous malignancy, osteoporosis, or …

Background Medication related osteonecrosis of the jaws (MRONJ), a rare side-effect of
antiresorptive medications, is described as exposed bone in the oral cavity that lasts for at …

Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-
resorptive medications. Despite its low incidence rate, this problem has gained attention in …

Objective The aim of this comprehensive systematic review and meta‐analysis was to
investigate the pathology and pathogenesis of medication‐related osteonecrosis of the jaw …

Medication-related osteonecrosis of the jaw (MRONJ) is primarily associated with
administering antiresorptive or antiangiogenic drugs. Despite significant research on …

Methods: A comprehensive review of the literature in English was conducted, using
databases such as PubMed, OVID, UpToDate, and Lexicomp to find relevant articles and …

Medication-related osteonecrosis of the jaw (MRONJ) is a complication caused by anti-
resorptive agents and anti-angiogenesis drugs. Since we wanted to write a protocol for a …

Objectives Medication‐related osteonecrosis of the jaws (MRONJ) is a serious condition
developed in up to 15% of patients who take antiresorptive medications. Its underlying …

The purpose of this study was to identify the patient populations at risk of medication‐related
osteonecrosis of the jaw (MRONJ) and determine which medical and dental comorbidities …